Anthera Pharmaceuticals Inc - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 14, 2016

Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - Anthera Pharmaceuticals Incex31_2.htm
EX-10.36 - EXHIBIT 10.36 - Anthera Pharmaceuticals Incex10_36.htm
EX-32.1 - EXHIBIT 32.1 - Anthera Pharmaceuticals Incex32_1.htm
EX-32.2 - EXHIBIT 32.2 - Anthera Pharmaceuticals Incex32_2.htm
EX-10.38 - EXHIBIT 10.38 - Anthera Pharmaceuticals Incex10_38.htm
EX-10.39 - EXHIBIT 10.39 - Anthera Pharmaceuticals Incex10_39.htm
EX-10.37 - EXHIBIT 10.37 - Anthera Pharmaceuticals Incex10_37.htm
EX-10.34 - EXHIBIT 10.34 - Anthera Pharmaceuticals Incex10_34.htm
EX-10.35 - EXHIBIT 10.35 - Anthera Pharmaceuticals Incex10_35.htm
EX-10.40 - EXHIBIT 10.40 - Anthera Pharmaceuticals Incex10_40.htm
EX-10.33 - EXHIBIT 10.33 - Anthera Pharmaceuticals Incex10_33.htm
EX-10.32 - EXHIBIT 10.32 - Anthera Pharmaceuticals Incex10_32.htm
EX-31.1 - EXHIBIT 31.1 - Anthera Pharmaceuticals Incex31_1.htm
10-K - FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 - Anthera Pharmaceuticals Incs3416010k.htm
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 

 
Anthera Pharmaceuticals, Inc.
Hayward, California
 
We hereby consent to the incorporation by reference in the Registration Statements on Form S-­3 (No. 333-175095, No. 333-179043, No. 333-187771, No. 333-187780 and No. 333-188679) and Form S-­8 (No. 333-165714, No. 333-168970, 333-172100, No. 333-180144 and No. 333-186679) of Anthera Pharmaceuticals, Inc. of our reports dated March X, 2016, relating to the consolidated financial statements and the effectiveness of Anthera Pharmaceuticals, Inc.’s internal controls over financial reporting, which appear in this Form 10-K.
 

 

San Jose, California
March 14, 2016
 
 
 

Anthera Pharmaceuticals Inc Reports